Injectables
Our injectable portfolio includes small molecules, peptides & recombinant proteins. These products would be manufactured in our 'Fill & Finish' sterile plant.
| Product | Strength |
| Octreotide Injection | 50, 100, 500mcg/ml single dose (1ml in 2ml Vial) |
| Octreotide Injection | 200, 1000mcg/ml Multidose Vial (5ml Vial) |
| Zoledronic Acid Injection | 4mg/5ml vial |
| Palonosetron injection | 0.25mg/5ml Vial |
| Icatibant Acetate Injection | 30mg/ 3ml PFS |
| Peg Filgrastim injection | 6mg/0.6m PFS |
| Sugammadex Sodium Injection | 100mg/ml - 2ml & 5ml vial |
| Regadenoson Monohydrate Injection | 0.4mg/5ml |
| Glycopyrrolate Injection | 0.2mg/ml in 1ml, 2ml, 5ml & 20ml vial |
| Etelcalcetide Injection | 2.5mg/0.5ml, 5 mg/ml, 10 mg/2ml |
Injectable US: filed 9 ANDAs, 4 approved, 1 launched, 4 under review
Injectable EU/UK: 4 Filed, 3 approved, 1 commercial
Injectable Emerging market: 24 Filed, 11 approved, 8 commercial
For more information about our existing portfolio and our pipeline products please e-mail us at info@usv.in
Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.